Search Count: 18
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2023-05-03 Classification: IMMUNOSUPPRESSANT/INHIBITOR Ligands: VN8, PGE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2023-05-03 Classification: IMMUNOSUPPRESSANT/INHIBITOR Ligands: VMB |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.28 Å Release Date: 2023-05-03 Classification: IMMUNOSUPPRESSANT/INHIBITOR Ligands: PEG, VMH |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2023-05-03 Classification: IMMUNOSUPPRESSANT/INHIBITOR Ligands: PGE, PEG, VML |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2023-05-03 Classification: IMMUNOSUPPRESSANT/INHIBITOR Ligands: PGE, VMQ, PEG, PG4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2023-05-03 Classification: IMMUNOSUPPRESSANT/INHIBITOR Ligands: VMW, PEG, GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2023-05-03 Classification: IMMUNOSUPPRESSANT/INHIBITOR Ligands: PEG, VN2 |
 |
Rip2 Kinase Catalytic Domain Complex With 2(4[(1,3Benzothiazol5Yl)Amino]6(2Methylpropane2Sulfonyl)Quinazolin7Yl)Oxy)Ethyl Phosphate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2019-07-17 Classification: TRANSFERASE Ligands: K9T, CA |
 |
Rip2 Kinase Catalytic Domain Complex With 2({4[(1,3Benzothiazol5Yl)Amino]6(2Methylpropane2Sulfonyl)Quinazolin7Yl}Oxy)Ethan1Ol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.62 Å Release Date: 2019-07-17 Classification: TRANSFERASE Ligands: KA2 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.87 Å Release Date: 2019-07-03 Classification: TRANSFERASE Ligands: K8K |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.79 Å Release Date: 2019-05-08 Classification: SIGNALING PROTEIN/INHIBITOR Ligands: M5J, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.25 Å Release Date: 2019-05-01 Classification: TRANSFERASE Ligands: JSW |
 |
Rip2 Kinase Catalytic Domain Complex With N(4,5Dimethyl1Hpyrazol3Yl)7Methoxy6(2Methylpropane2Sulfonyl)Quinolin4Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2018-11-07 Classification: TRANSFERASE Ligands: GEZ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.56 Å Release Date: 2017-07-05 Classification: transferase/transferase inhibitor Ligands: 7MJ |
 |
The Identification And Pharmacological Characterization Of 6-(Tert-Butylsulfonyl)-N-(5-Fluoro-1H-Indazol-3-Yl)Quinolin-4-Amine (Gsk583), A Highly Potent And Selective Inhibitor Of Rip2 Kinase, Compound 3 Complex
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2016-05-18 Classification: Transferase/Transferase Inhibitor Ligands: 6GE, SO4 |
 |
The Identification And Pharmacological Characterization Of 6-(Tert-Butylsulfonyl)-N-(5-Fluoro-1H-Indazol-3-Yl)Quinolin-4-Amine (Gsk583), A Highly Potent And Selective Inhibitor Of Rip2 Kinase, Gsk583 Complex
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2016-05-18 Classification: Transferase/Transferase Inhibitor Ligands: 6GD |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2016-03-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 65U |
 |
X-Ray Structure Of Receptor Interacting Protein 1 (Rip1)Kinase Domain With A 1-Aminoisoquinoline Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.57 Å Release Date: 2013-11-20 Classification: TRANSFERASE Ligands: MG, Q1A |